Weight-Loss drug could boost IVF success for overweight women
Disease control
Recruiting now
This study is testing whether taking the weight-loss medication semaglutide for 12 weeks before IVF treatment improves embryo quality in overweight and obese women. Researchers want to see if this pre-treatment leads to more high-quality embryos compared to standard IVF without t…
Phase: PHASE4 • Sponsor: Fundacion Dexeus • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC